UnknownNot Applicable

Diagnostic Accuracy of a Specialized Pro Forma in Assessing Morbidly Adherent Placenta With Correlation to Intra-operative Findings

Egypt21 participantsStarted 2021-06-18

Plain-language summary

This study objective is to assess the accuracy of a specialized pro forma in suggesting the probability of Morbidly Adherent Placenta, its extent and its correlation with intraoperative findings.

Who can participate

Age range

28 Years – 42 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age group 28:42 years. * Pregnant women in their late third trimester (34 0/7 weeks: 37 0/7 weeks). * With a single living fetus in the current pregnancy. * A previous delivery by at least 1 cesarean section or history of uterine surgery including (surgical evacuation, myomectomy or endometrium ablation) * Having an anterior placenta previa or anterior low-lying placenta by ultrasound assessment. Exclusion Criteria: * Cases with a non-previa placenta, posterior low lying placenta or posterior previa placenta. * Maternal chronic medical disorders( diabetes mellitus, hypertension) * Patients presented with severe attack of bleeding. * Patients presented with rupture of membrane. * Emergency delivery regardless the cause.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Clinical significance of ultrasound signs in morbidly adherent placenta(most sensitive US sign)

Timeframe: June 2021- July 2022

Accuracy of our specialized pro forma in assessing extent of morbidly adherent placenta(focal , diffuse)

Timeframe: June 2021- July 2022

Accuracy of our specialized pro forma in assessing depth of invasion of placenta accreta spectrum (accrete, increta and percreta)

Timeframe: June 2021- July 2022

Trial details

NCT IDNCT04938050

SponsorCairo University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-01-30

View on ClinicalTrials.gov More Morbidly Adherent Placenta trials

Who can participate

Age range

28 Years – 42 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Clinical significance of ultrasound signs in morbidly adherent placenta(most sensitive US sign)

Timeframe: June 2021- July 2022

Accuracy of our specialized pro forma in assessing extent of morbidly adherent placenta(focal , diffuse)

Timeframe: June 2021- July 2022

Accuracy of our specialized pro forma in assessing depth of invasion of placenta accreta spectrum (accrete, increta and percreta)

Timeframe: June 2021- July 2022